EUVIMEDEUVIMED entdecken
Open Access

Chikungunya infection in returned travellers: results from the GeoSentinel network, 2005–2020

Rachel Bierbrier, Emilie Javelle iD, Francesca F Norman iD, Lin Hwei Chen, Emmanuel Bottieau, Eli Schwartz, Karin Leder, Kristina M Angelo, Rhett J Stoney iD, Michael Libman iD, Davidson H Hamer, Ralph Huits und 4 weitere

Journal of Travel Medicine · 01.03.2024 · 31 (2)

DOI: 10.1093/jtm/taae005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Travel Medicine, online erschienen am 09.01.2024. Verfasst von Rachel Bierbrier und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Department of Medicine, McGill University, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Chikungunya Fever, Travel-Related Illness. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS, NCEZID CDC HHS, Cooperative Agreement between the US Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chikungunya is an important travel-related disease because of its rapid geographical expansion and potential for prolonged morbidity. Improved understanding of the epidemiology of travel-related chikungunya infections may influence prevention strategies including education and vaccination.

Methods

We analysed data from travellers with confirmed or probable chikungunya reported to GeoSentinel sites from 2005 to 2020. Confirmed chikungunya was defined as a compatible clinical history plus either virus isolation, positive nucleic acid test or seroconversion/rising titre in paired sera. Probable chikungunya was defined as a compatible clinical history with a single positive serology result.

Results

1202 travellers (896 confirmed and 306 probable) with chikungunya were included. The median age was 43 years (range 0–91; interquartile range [IQR]: 31–55); 707 (58.8%) travellers were female. Most infections were acquired in the Caribbean (28.8%), Southeast Asia (22.8%), South Central Asia (14.2%) and South America (14.2%). The highest numbers of chikungunya cases reported to GeoSentinel were in 2014 (28.3%), 2015 (14.3%) and 2019 (11.9%). The most frequent reasons for travel were tourism (n = 592; 49.3%) and visiting friends or relatives (n = 334; 27.7%). The median time to presentation to a GeoSentinel site was 23 days (IQR: 7–52) after symptom onset. In travellers with confirmed chikungunya and no other reported illnesses, the most frequently reported symptoms included musculoskeletal symptoms (98.8%), fever/chills/sweats (68.7%) and dermatologic symptoms (35.5%). Among 917 travellers with information available, 296 (32.3%) had a pretravel consultation.

Conclusions

Chikungunya was acquired by international travellers in almost 100 destinations globally. Vector precautions and vaccination where recommended should be integrated into pretravel visits for travellers going to areas with chikungunya or areas with the potential for transmission. Continued surveillance of travel-related chikungunya may help public health officials and clinicians limit the transmission of this potentially debilitating disease by defining regions where protective measures (e.g. pretravel vaccination) should be strongly considered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chikungunya FeverTravel-Related IllnessAdolescentAdultAgedAged, 80 and overChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleMiddle AgedYoung AdultAsiaSouth America

Stichwörter der Autor:innen

Caribbeanarbovirusarthritispreventionsentinelvaccinationvector borne virus

Autor:innen und Institutionen

  • Division of Dermatology, Department of Medicine, McGill University, Montreal, Quebec, Canada.
  • The J. D. MacLean Centre for Tropical Diseases, McGill University, Montreal, Quebec, Canada.
  • Unité Parasitologie et Entomologie, Département Microbiologie et Maladies Infectieuses, Institut de Recherche Biomédicale des Armées (IRBA), Centre National de Référence du Paludisme, 13005 Marseille, France.
  • Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, 13284 Marseille, France.
  • National Referral Unit for Tropical Diseases, Infectious Diseases Department, Ramón y Cajal University Hospital, CIBERINFEC, IRYCIS, Madrid, Spain.
  • Universidad de Alcalá, Madrid, Spain.

ORCID-Profile: Emilie Javelle, Francesca F Norman, Rhett J Stoney, Michael Libman

Förderung

  • Intramural CDC HHS
  • NCEZID CDC HHS
  • Cooperative Agreement between the US Centers for Disease Control and Prevention
  • International Society of Travel Medicine
  • Public Health Agency of Canada

Zitieren

APA

Bierbrier, R., Javelle, E., Norman, F. F., Chen, L. H., Bottieau, E., Schwartz, E., Leder, K., Angelo, K. M., Stoney, R. J., Libman, M., Hamer, D. H., Huits, R., Connor, B. A., Simon, F., Barkati, S., & GeoSentinel Network (2024). Chikungunya infection in returned travellers: results from the GeoSentinel network, 2005–2020. Journal of Travel Medicine, 31(2). https://doi.org/10.1093/jtm/taae005

Vancouver

Bierbrier R, Javelle E, Norman FF, Chen LH, Bottieau E, Schwartz E, et al. Chikungunya infection in returned travellers: results from the GeoSentinel network, 2005–2020. Journal of Travel Medicine. 2024;31(2). doi:10.1093/jtm/taae005

BibTeX
@article{Bierbrier2024,
  author = {Bierbrier, Rachel and Javelle, Emilie and Norman, Francesca F and Chen, Lin Hwei and Bottieau, Emmanuel and Schwartz, Eli and Leder, Karin and Angelo, Kristina M and Stoney, Rhett J and Libman, Michael and Hamer, Davidson H and Huits, Ralph and Connor, Bradley A and Simon, Fabrice and Barkati, Sapha and GeoSentinel Network, GeoSentinel Network},
  title = {Chikungunya infection in returned travellers: results from the GeoSentinel network, 2005–2020},
  journal = {Journal of Travel Medicine},
  year = {2024},
  volume = {31},
  number = {2},
  doi = {10.1093/jtm/taae005}
}
Kostenlos starten →